Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2021 Mar 15.
Published in final edited form as: Mater Lett. 2019 Dec 28;263:127282. doi: 10.1016/j.matlet.2019.127282

Novel Zinc / Tungsten Carbide Nanocomposite as Bioabsorbable Implant

Zeyi Guan a, Chase S Linsley b, Injoo Hwang a, Gongcheng Yao c, Benjamin M Wu b,c,d,e, Xiaochun Li a,c,*
PMCID: PMC7346885  NIHMSID: NIHMS1604012  PMID: 32647402

Abstract

There is a lack of bioabsorbable materials with adequate mechanical strength suitable for implant applications that provide temporary support while tissue integrity is restored, especially for pediatric applications. Bioabsorbable metals have emerged as an attractive choice due to their combination of strength, ductility, and biocompatibility in vivo. Zinc has shown great promise as a bioabsorbable metal, but the weak mechanical properties of pure zinc limit its application as an implant material. This study investigates zinc-tungsten carbide (Zn-WC) nanocomposite as a novel material for bioabsorbable metallic implants. Ultrasound-assisted powder compaction was used to fabricate Zn-WC nanocomposites. This study includes the material characterization of microstructure, microhardness, and degradability. Results showed that tungsten carbide nanoparticles enhanced the mechanical properties of Zn, and maintained the favorable corrosion rate of pure Zn. These results encourage further investigation of Zn-WC nanocomposites for biomedical applications with the ultimate goal of creating safe and efficacious bioabsorbable metallic implants for many clinical applications.

Keywords: Nanocomposites, Zinc, Bioabsorbable implant

1. Introduction

Permanent implant materials are frequently used in clinical cases that only require their presence temporarily. These situations are less-than-ideal as the long-term presence of implants is associated with many complications, including infections [1], implant migration [2], altered tissue growth [3, 4], stress shielding [5], toxicity [6-8], and subsequent surgeries. Permanent implants are also unsuitable for the pediatric patient population due to their inability to accommodate growth [9-11], Conversely, bioabsorbable implant materials provide transient support that allows for the restoration of a tissue’s physiological integrity followed by complete reabsorption of the implants. Most bioabsorbable implants are currently polymer-based [12]; however, their lower mechanical strength and viscoelastic behavior have limited their clinical use for load-bearing applications, such as bone staples, fixation plates, ACL screws, cardiovascular and nonvascular stents, and spinal fusion cages and clips [13, 14], Bioabsorbable metallic implants are an attractive alternative. Metals have a higher mechanical strength and toughness necessary for load-bearing applications and have a proven history of biocompatibility in vivo.

Magnesium- and iron-based alloys have been extensively studied as candidates for bioabsorbable metallic implants with some success [15], However, their drawbacks include the non-favorable corrosion rate and chronic inflammatory response[16, 17], Zinc (Zn) has recently generated interest as a suitable candidate for bioabsorbable metallic implants. As an essential element in basic biological functions, Zn is required for the proper function of numerous proteins that regulate the proliferation, differentiation, and apoptosis of cells, and is involved in nucleic acid metabolism, signal transduction, and gene expression [18], Therefore, living tissues have transport mechanisms that regulate Zn levels, which combat against toxic cellular levels [19, 20], Additionally, recent in vivo studies have shown that Zn implants demonstrate steady corrosion rates with no severe inflammation, platelet aggregation, thrombosis or intimal hyperplasia [21-23], Furthermore, Zn has a greater elongation to failure (60-80%) than magnesium (13%) and iron (18%) [22], This can positively influence the fatigue resistance and fracture toughness of the Zn- based implants. However, insufficient mechanical strength inhibits pure Zn from being used for load-bearing applications [24], Alloying can properly enhance the strength, but at the cost of other favorable properties, such as corrosion rate [25], ductility [26], and biocompatibility [27], Additionally, there are limits to the extent that the properties of metals can be improved through alloying.

Metals reinforced with nanoparticles have emerged as an important class of materials that offer significantly enhanced mechanical, thermo-physical, and electrical properties [28, 29], It is therefore believed that nanoparticles can also be added to Zn melts to significantly enhance Zn’s mechanical properties. In this study, non-cytotoxic tungsten carbide (WC) nanoparticles [30] were incorporated into Zn as the nano-reinforcement through ultrasound-assisted powder compaction. WC nanoparticles dispersion in Zn matrix was studied, as well as its impact on hardness. Furthermore, the degradation rate in simulated body fluid was studied, and the change in surface morphology after immersion testing was evaluated. Compared with conventional strengthening methods, e.g. alloying, which commonly has a highly increase corrosion rate [26], Zn matrix nanocomposite fabricated in this work provided high strength and had a corrosion rate similar to pure Zn.

2. Material and Methods

2.1. Fabrication and characterization of Zn-WC Nanocomposites

Ultrasound-assisted powder compaction was used to fabricate Zn-WC nanocomposites (Fig. 1). Tungsten carbide (WC) nanoparticles (200 nm average diameter) were well-mixed with Zn powders (50 pm average diameter) by mechanical shaking. The powder mixture was compacted in cylindrical stainless steel mold (inner diameter of 2 cm) by a hydraulic press machine for Zn- WC pellets. These pellets were melted with ultrasound processing (20 kHz) under an inert atmosphere (Ar) at 450°C for 30 minutes and allowed to cool to room temperature. The distribution and dispersion of WC nanoparticles, as well as the element composition, were characterized by scanning electron microscopy (SEM), transmission electron microscopy (TEM) and energy- dispersive X-ray spectroscopy (EDX).

Figure 1.

Figure 1.

Schematic of Zn-WC nanocomposite fabrication via ultrasound-assisted power compaction

2.2. Biodegradation studies of Zn-WC nanocomposite microwires

Zn-WC nanocomposite was cast into a borosilicate tube by vacuum and went through thermal fiber drawing for microwires [31] to represent bioabsorbable devices for biodegradation characterization. The immersion test (ASTM G31-72) was carried out, where samples were kept in Simulated Body Fluid (SBF) for 14 days at 37°C. The SBF used in this study had ionic concentrations equal to that of human blood plasma, as well as an equal pH value (Table 1). Inductively coupled plasma optical emission spectrometer (ICP-OES) and ICP- mass spectrometer (ICP-MS) were carried out for Zn and W ion concentration measurement in the SBF. The changes in the surface morphologies after immersion were studied by environmental scanning electron microscopy (ESEM). The analysis was conducted with a ZEISS Supra 40 Variable Pressure SEM (VP-SEM) equipped with a Thermo Noran System 6 energy-dispersive X-ray spectroscopy (EDS) system. Vickers Microhardness test was performed before and after the emersion test.

Table 1.

Ion concentration and pH values of simulated body fluid versus human blood plasma

Ions SBF (mM) Human Blood Plasma (mM)
Na+ 142 142
K+ 5 5
Mg2+ 1.5 1.5
Ca2+ 2.5 2.5
Cl 147.8 103
HCO3 4.2 27
HPO42− 1 1
SO42− 0.5 0.5
pH 7.4 7.4

2.3. Statistical Analysis

The statistical significance of differences between groups during immersion testing was determined using one-way ANOVA followed by Tukey post-hoc analysis. The SPSS statistical software package 24.0 for Windows (IBM, Armonk, NY, USA) was used for statistical analysis. Significance was established by a value of p < 0.05. Data are expressed as mean ± standard deviation (SD).

3. Result and discussion

3.1. Zn-WC Nanocomposite Microstructure

The microstructure of Zn-WC nanocomposites was shown in Fig. 2a-b with different magnifications. The bright phases correspond to WC, and the dark-phase regions are Zn. WC nanoparticles are observed with homogeneous dispersion with no severe sintering (Fig. 2b), because the ultrasound processing and reasonably good wettability between WC and molten Zn enabled nanoparticles self-dispersion [32], TEM image further reveals the homogeneous dispersion of WC nanoparticles, shown in Fig. 2c. The darker phase indicates the microstructure of the single crystal WC, as confirmed by selected area electron diffraction. WC obtains a hexagonal crystalline structure, where (111) plane and (201) plane are presented with an angle of 27° as indicated in Fig. 2d.

Figure 2.

Figure 2.

(a) SEM images of WC nanoparticles homogeously dispersed in Zn matrix. (b) Magnified SEM image of dispersed WC nanoparticles of 150nm with no severe sintering. (c) TEM image of Zn-WC nanocomposite. (d) Diffraction patern of WC on the darker phase after fast Fourier tranformation.

3.2. Microhardness of Zn-WC Nanocomposites

Vickers microhardness was determined for both pure Zn and Zn-WC nanocomposites with different nano-reinforcement concentration. The Vickers microhardness for pure Zn was 40.6 HV and 46.7, 50.6, 54.2 and 60.1 HV for 2.5, 5, 7.5 and 10 vol.% of Zn-WC nanocomposites (indicated as Zn-10WC), respectively (Fig. 3a). 10 vol.% WC nanoparticles enhanced the microhardness by 48%. This is primarily due to the Orowan strengthening that nanoparticles block the dislocation motion. The Vickers microhardness was measured after 14 days of immersion in the simulated body fluid (SBF) solution to evaluate mechanical integrity. No statistically significant change was detected in Fig. 3b.

Figure 3.

Figure 3.

Biodegradability of pure zinc and Zn-WC nanocomposite. (a) Vickers microhardness of Zn- WC nanocomposites vs. WC vol.% (b) Comparing the Vickers hardness of pure Zn and Zn-WC (10 vol. %) nanocomposites before and after 14 days of immersion in SBF. (c) Static immersion of Zn-WC micro-wires in SBF (n=3). No statistically significant difference (p > 0.05) was measured in Zn release between samples with increasing WC nanoparticle content based on one-way ANOVA. SEM images of Zn- WC nanocomposite micro-wire before (d) and after (e) immersion in SBF for 14 days.

3.3. Biodegradation of Zn-WC microwires

The results from the immersion test show that the number of Zn ions released from the Zn-WC nanocomposites are statistically the same regardless of the volume fraction of WC nanoparticles and was similar to that of pure Zn micro-wires based on one-way ANOVA (Fig. 3c). These results suggest that Zn retains the favorable degradation rate with the addition of WC nanoparticles. The degradation rate of the Zn-WC micro-wires was linear during the 14-day study length. The average corrosion rate of each sample per day was 0.25 ~ 0.4, 0.33 ~ 0.43, 0.31 ~ 0.33 and 0.25 ~ 0.26 pg/mm2/day at days 1, 3, 7 and 14, respectively, shown in Table 2. These levels of Zn ion release are likely to be well tolerated in vivo. The National Academy of Medicine has set the recommended daily intake value of Zn at 2-3 mg/day for infants up to 8-11 mg/day for adults [33], and normal serum and urine levels in adults have been reported as 1 pg/mL and 0.5 mg/g creatinine, respectively. Therefore, the toxic potential of the daily dose of Zn released from a Zn-based implant should be negligible[21, 34], Additionally, no detectable levels of tungsten were released from Zn-WC nanocomposite microwires after 14 days of static immersion in SBF as measured by ICP-MS with a lower quantifiable limit of 0.5 ppb (0.5 ng/mL). Tungsten has historically been considered an inert metal; however, there are concerns that accumulation of tungsten within the bone may alter the bone biology as well as result in higher exposure levels within the bone marrow, which contains part of the developing immune system [35], However, relatively high doses of tungsten (15-500 ppm) are used in such toxicity studies [35-37], Taken altogether, these results indicate that WC remains reactively stable with minimal toxic potential in vivo [30] and its impact on the corrosion rate of Zn-based implants is negligible.

Table 2.

Average cumulative Zn ion release at day 14 of the immersion test

Zn Zn-2.5WC Zn-5WC Zn-7.5WC Zn-10WC
Zn ion release (gg/mm2) 0.329±0.068 0.346±0.047 0.299±0.047 0.305±0.070 0.338±0.090
Significance level P N/A 0.49 0.21 0.39 0.78

Fig. 3d and 3e show the surface morphologies of the Zn-WC nanocomposite micro-wires before and after soaking in SBF for 14 days, presenting that the surface immersed in the SBF for 14 days was similar to that before testing. A large amount of salt precipitation forms a layer to cover the sample’s surface. According to EDS results, it is reasonable to assume that the layer of biodegradation products may contain ZnO, Zn(OH)2, Zn3(PC>4)2, and Ca3(PC>4)2 based on the composition and insolubility of by-products in water and SBF.

4. Conclusion

In summary, ultrasound-assisted powder compaction was used to successfully fabricate Zn-WC nanocomposites. Zn - 10 vol.% WC gained a 48% increase in hardness, which did not change after 14 days of biodegradation testing. Evaluation of the biodegradation showed that the WC nanoparticles did not impact the release rate of Zn ions, and no detectable levels of tungsten ions were released from any of the nanocomposites. These results suggest the novel Zn-WC nanocomposites retain the favorable biodegradation profile of pure Zn necessary for bioabsorbable metallic implant applications while enhancing the mechanical properties. Further material characterization is required, including fatigue testing, electrochemical biocorrosion analysis, and both in vitro and in vivo biocompatibility testing to verify the suitability of nanocomposites for bioabsorbable metallic implant applications.

Highlights:

  • Zinc/Tungsten Carbide matrix nanocomposite is manufactured via ultrasound-assisted powder compaction.

  • The hardness of Zn/Tungsten Carbide is 48% higher than pure zinc.

  • The corrosion rate of Zn/Tungsten Carbide is statistically the same as pure zinc, with not toxic tungsten ion leaching.

  • Zn/Tungsten carbide can be applied to bioabsorbable metallic implant.

ACKNOWLEDGMENTS

Research reported in this publication was supported by the National Heart, Lung, And Blood Institute of the National Institutes of Health under Award Number R01HL143465 and by National Science Foundation under CMMI Award Number 1449395. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health and the National Science Foundation. We acknowledge Dr. Shane Que Hee, School of Public Health, University of California, Los Angeles, for his technical support with the ICP-MS, and Dr. Erika Callagon La Plante from Dr. Gaurav Sant’s Lab, Civil and Environmental Engineering, University of California, Los Angeles, for her technical support with the ICP-OES.

Footnotes

Publisher's Disclaimer: This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we arc providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

Declaration of Interest Statement

All authors in the author list declare that there is no conflict of interest.

REFERENCES

  • [1].Moriarty TF, Schlegel U, Perren S, Richards RG, Infection in fracture fixation: can we influence infection rates through implant design?, Journal of Materials Science: Materials in Medicine 21(3) (2010) 1031–1035. [DOI] [PubMed] [Google Scholar]
  • [2].Zilkens C, Djalali S, Bittersohl B, Kalicke T, Kraft C, Krauspe R, Jager M, Migration pattern of cementless press fit cups in the presence of stabilizing screws in total hip arthroplasty, European journal of medical research 16(3) (2011) 127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [3].Nakata T, Fujii K, Fukunaga M, Shibuya M, Kawai K, Kawasaki D, Naito Y, Ohyanagi M, Masuyama T, Morphological, Functional, and Biological Vascular Healing Response 6 Months After Drug- Eluting Stent Implantation: A Randomized Comparison of Three Drug-Eluting Stents, Catheterization and Cardiovascular Interventions 88(3) (2016) 350–357. [DOI] [PubMed] [Google Scholar]
  • [4].Kim MS, Dean LS, In-stent restenosis, Cardiovascular therapeutics 29(3) (2011) 190–198. [DOI] [PubMed] [Google Scholar]
  • [5].Sumitomo N, Noritake K, Flattori T, Morikawa K, Niwa S, Sato K, Niinomi M, Experiment study on fracture fixation with low rigidity titanium alloy, Journal of Materials Science: Materials in Medicine (4)(2008)1581–1586. [DOI] [PubMed] [Google Scholar]
  • [6].Gomes CC, Moreira LM, Santos VJ, Ramos AS, Lyon JP, Soares CP, Santos FV, Assessment of the genetic risks of a metallic alloy used in medical implants, Genetics and molecular biology 34(1) (2011) 116–121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [7].Okazaki Y, Gotoh E, Comparison of metal release from various metallic biomaterials in vitro, Biomaterials 26(1) (2005) 11–21. [DOI] [PubMed] [Google Scholar]
  • [8].Cadosch D, Chan E, Gautschi OP, Filgueira L, Metal is not inert: role of metal ions released by biocorrosion in aseptic loosening—current concepts, Journal of Biomedical Materials Research Part A: An Official Journal of The Society for Biomaterials, The Japanese Society for Biomaterials, and The Australian Society for Biomaterials and the Korean Society for Biomaterials 91(4) (2009) 1252–1262. [DOI] [PubMed] [Google Scholar]
  • [9].Zartner P, Cesnjevar R, Singer H, Weyand M, First successful implantation of a biodegradable metal stent into the left pulmonary artery of a preterm baby, Catheterization and Cardiovascular Interventions 66(4) (2005) 590–594. [DOI] [PubMed] [Google Scholar]
  • [10].BerryhilI WE, Rimell FL, Ness J, Marentette L, Haines SJ, Fate of rigid fixation in pediatric craniofacial surgery, Otolaryngology—Head and Neck Surgery 121(3) (1999) 269–273. [DOI] [PubMed] [Google Scholar]
  • [11].Yaremchuk MJ, Fiala T, Barker F, Ragland R, The effects of rigid fixation on craniofacial growth of rhesus monkeys, Plastic and reconstructive surgery 93(1) (1994) 1–10; discussion 11–5. [PubMed] [Google Scholar]
  • [12].Nasution AK, Hermawan H, Degradable biomaterials for temporary medical implants, Biomaterials and Medical Devices, Springer; 2016, pp. 127–160. [Google Scholar]
  • [13].Smit T, Engels TA, Sontjens SH, Govaert L, Time-dependent failure in load-bearing polymers: a potential hazard in structural applications of polylactides, Journal of Materials Science: Materials in Medicine 21(3) (2010) 871–878. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [14].Bergstroem JS, Hayman D, An overview of mechanical properties and material modeling of polylactide (PLA) for medical applications, Annals of biomedical engineering 44(2) (2016) 330–340. [DOI] [PubMed] [Google Scholar]
  • [15].Haude M, Ince H, Abizaid A, Toelg R, Lemos PA, von Birgelen C, Christiansen EH, Wijns W, Neumann FJ, Kaiser C, Eeckhout E, Lim ST, Escaned J, Garcia-Garcia HM, Waksman R, Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month results of a prospective, multicentre, non-randomised, first-in-man trial, Lancet 387(10013) (2016) 31–39. [DOI] [PubMed] [Google Scholar]
  • [16].Virtanen S, Biodegradable Mg and Mg alloys: Corrosion and biocompatibility, Materials Science and Engineering: B 176(20) (2011) 1600–1608. [Google Scholar]
  • [17].Liu B, Zheng Y, Effects of alloying elements (Mn, Co, Al, W, Sn, B, C and S) on biodegradability and in vitro biocompatibility of pure iron, Acta biomaterialia 7(3) (2011) 1407–1420. [DOI] [PubMed] [Google Scholar]
  • [18].Hambidge KM, Krebs NF, Zinc deficiency: a special challenge, The Journal of nutrition 137(4) (2007)1101–1105. [DOI] [PubMed] [Google Scholar]
  • [19].Xu L, Yu G, Zhang E, Pan F, Yang K, In vivo corrosion behavior of Mg-Mn-Zn alloy for bone implant application, Journal of Biomedical Materials Research Part A: An Official Journal of The Society for Biomaterials, The Japanese Society for Biomaterials, and The Australian Society for Biomaterials and the Korean Society for Biomaterials 83(3) (2007) 703–711. [DOI] [PubMed] [Google Scholar]
  • [20].Eide DJ, Zinc transporters and the cellular trafficking of zinc, Biochimica et Biophysica Acta (BBA)- Molecular Cell Research 1763(7) (2006) 711–722. [DOI] [PubMed] [Google Scholar]
  • [21].Bowen PK, Drelich J, Goldman J, Zinc exhibits ideal physiological corrosion behavior for bioabsorbable stents, Advanced materials 25(18) (2013) 2577–2582. [DOI] [PubMed] [Google Scholar]
  • [22].Drelich AJ, Zhao S, Guillory II RJ, Drelich JW, Goldman J, Long-term surveillance of zinc implant in murine artery: Surprisingly steady biocorrosion rate, Acta biomaterialia 58 (2017) 539–549. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [23].Yang H, Wang C, Liu C, Chen H, Wu Y, Han J, Jia Z, Lin W, Zhang D, Li W, Evolution of the degradation mechanism of pure zinc stent in the one-year study of rabbit abdominal aorta model, Biomaterials 145 (2017) 92–105. [DOI] [PubMed] [Google Scholar]
  • [24].Katarivas Levy G, Goldman J, Aghion E, The prospects of zinc as a structural material for biodegradable implants—A review paper, Metals 7(10) (2017) 402. [Google Scholar]
  • [25].Kafri A, Ovadia S, Goldman J, Drelich J, Aghion E, The suitability of Zn-1.3% Fe alloy as a biodegradable implant material, Metals 8(3) (2018) 153. [Google Scholar]
  • [26].Mostaed E, Sikora-Jasinska M, Mostaed A, Loffredo S, Demir A, Previtali B, Mantovani D, Beanland R, Vedani M, Novel Zn-based alloys for biodegradable stent applications: design, development and in vitro degradation, journal of the mechanical behavior of biomedical materials 60 (2016) 581–602. [DOI] [PubMed] [Google Scholar]
  • [27].Bowen PK, Seitz JM, Guillory RJ, Braykovich JP, Zhao S, Goldman J, Drelich JW, Evaluation of wrought Zn-AI alloys (1, 3, and 5 wt% Al) through mechanical and in vivo testing for stent applications, Journal of Biomedical Materials Research Part B: Applied Biomaterials 106(1) (2018) 245–258. [DOI] [PubMed] [Google Scholar]
  • [28].Chen L-Y, Xu J-Q, Choi H, Pozuelo M, Ma X, Bhowmick S, Yang J-M, Mathaudhu S, Li X-C, Processing and properties of magnesium containing a dense uniform dispersion of nanoparticles, Nature 528(7583) (2015) 539. [DOI] [PubMed] [Google Scholar]
  • [29].Pan S, Sokoluk M, Cao C, Guan Z, Li X, Facile fabrication and enhanced properties of Cu-40 wt% Zn/WC nanocomposite, Journal of Alloys and Compounds 784 (2019) 237–243. [Google Scholar]
  • [30].Bastian S, Busch W, Kuhnel D, Springer A, Meissner T, Holke R, Scholz S, Iwe M, Pompe W, Gelinsky M, Potthoff A, Richter V, Ikonomidou C, Schirmer K, Toxicity of Tungsten Carbide and Cobalt- Doped Tungsten Carbide Nanoparticles in Mammalian Cells in Vitro, Environmental Health Perspectives 117(4) (2009) 530–536. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [31].Zhao JZ, Javadi A, Lin TC, Hwang I, Yang YC, Guan ZY, Li XC, Scalable Manufacturing of Metal Nanoparticles by Thermal Fiber Drawing, Journal of Micro and Nano-Manufacturing 4(4) (2016). [Google Scholar]
  • [32].Chen LY, Peng JY, Xu JQ, Choi H, Li XC, Achieving uniform distribution and dispersion of a high percentage of nanoparticles in metal matrix nanocomposites by solidification processing, Scripta Materialia 69(8) (2013) 634–637. [Google Scholar]
  • [33].Russell R, Beard JL, Cousins RJ, Dunn JT, Ferland G, Hambidge K, Lynch S, Penland J, Ross A, Stoecker B, Dietary reference intakes for vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc, A Report of the Panel on Micronutrients, Subcommittees on Upper Reference Levels of Nutrients and of Interpretation and Uses of Dietary Reference Intakes, and the Standing Committee on the Scientific Evaluation of Dietary Reference Intakes Food and Nutrition Board Institute of Medicine (2001). [Google Scholar]
  • [34].Xu L, Yu G, Zhang E, Pan F, Yang K, In vivo corrosion behavior of Mg-Mn-Zn alloy for bone implant application, Journal of biomedical materials research Part A 83(3) (2007) 703–711. [DOI] [PubMed] [Google Scholar]
  • [35].Guilbert C, Kelly A, Petruccelli L, Lemaire M, Mann K, Exposure to tungsten induces DNA damage and apoptosis in developing B lymphocytes, Leukemia 25(12) (2011) 1900. [DOI] [PubMed] [Google Scholar]
  • [36].Bolt AM, Mann KK, Tungsten: an emerging toxicant, alone or in combination, Current environmental health reports 3(4) (2016) 405–415. [DOI] [PubMed] [Google Scholar]
  • [37].Kelly AD, Lemaire M, Young YK, Eustache JH, Guilbert C, Molina MF, Mann KK, In vivo tungsten exposure alters B-cell development and increases DNA damage in murine bone marrow, toxicological sciences 131(2) (2012) 434–446. [DOI] [PubMed] [Google Scholar]

RESOURCES